회사 개요
The Cigna Group operates as a prominent entity within the Healthcare sector, specifically focusing on Healthcare Plans by delivering insurance and related services across the United States through its subsidiaries. The company's operational structure is divided into two primary segments: Evernorth Health Services, which encompasses Pharmacy Benefit Services and Specialty and Commercial Health Solutions, alongside Cigna Healthcare. This diversified business model supports a significant workforce of 65,669 employees, reflecting its extensive reach within the American healthcare infrastructure. With a total market capitalization of $74.38B and annual revenue reaching $274.90B over the trailing twelve months, the firm demonstrates substantial scale in the insurance industry. These valuation and revenue figures indicate that The Cigna Group holds a massive market position, positioning it as a major player capable of influencing industry standards while managing complex healthcare delivery networks.
재무 건전성
The company reported total revenue of $274.90B for the trailing twelve months, generating a net income of $5.96B and an EBITDA of $12.05B. The significant disparity between the high revenue figure and the lower net income reveals a cost structure characterized by substantial operating expenses, typical of the healthcare insurance industry where gross margins are inherently constrained. Free cash flow stands at $9.77B, a metric that underscores the company's robust financial flexibility to fund operations, service debt obligations, and potentially pursue strategic investments without relying on external financing. Profitability is further detailed by three key margins: a Gross Margin of 9.3%, an Operating Margin of 3.5%, and a Profit Margin of 2.2%, all of which indicate that the company retains a relatively small portion of revenue as profit after covering the high costs associated with claims, administrative overhead, and pharmacy benefit services. Regarding leverage, the company holds $8.73B in cash against $31.46B in total debt, resulting in a Debt to Equity ratio of 75.14, which suggests a balance sheet that is moderately leveraged given the capital-intensive nature of the healthcare services sector. Liquidity is assessed by the Current Ratio of 0.85, a figure below 1.0 that indicates current liabilities exceed current assets, implying the company relies heavily on operating cash flows to meet short-term obligations rather than liquid asset reserves. Return on Equity is calculated at 15.1% while Return on Assets sits at 4.1%, metrics that reveal management's effectiveness in generating returns for shareholders relative to the equity base and utilizing the total asset base efficiently.
밸류에이션 평가
Valuation multiples for The Cigna Group include a Trailing Twelve Months P/E Ratio of 12.55 and a Forward P/E of 8.32, where the lower forward multiple implies that the market expects earnings to expand significantly in the coming years to justify the current stock price. The Price to Book ratio is recorded at 1.76, indicating that the market values the company at a premium of 76% over its book value, reflecting intangible assets like brand equity and regulatory licenses that are not fully captured on the balance sheet. Alternative valuation perspectives are provided by the Price to Sales ratio of 0.27 and an EV/EBITDA of 7.99, metrics that suggest the stock is priced conservatively relative to its sales volume and enterprise earnings power. The stock's trading range over the past year is bounded by a 52-Week High of $350.00 and a 52-Week Low of $239.51, and assuming the current market price aligns with the trailing P/E of 12.55 against a recent market context, the valuation sits at a level that requires comparison to this historical range to gauge relative attractiveness. The Beta value of 0.27 indicates that the stock's price volatility is significantly lower than the broader market, suggesting a defensive characteristic where the share price tends to remain relatively stable during periods of market turbulence.
Growth & Income
Growth dynamics for The Cigna Group show a Revenue Growth rate of 10.4% year-over-year contrasted with an Earnings Growth rate of -9.3%, indicating that while top-line sales are expanding rapidly, net profitability is currently contracting, likely due to rising claims costs or investment fluctuations affecting the bottom line. As a dividend payer, the company offers a Dividend Yield of 2.2% with a Payout Ratio of 27.2%, a low payout ratio that suggests the dividend is highly sustainable given the earnings generation and free cash flow available to shareholders. The low payout ratio allows the company to retain a substantial majority of its earnings for reinvestment into growth initiatives, acquisitions, or balance sheet strengthening rather than distributing all profits to investors. In summary, the overall growth and income profile presents a scenario of robust revenue expansion offset by temporary earnings pressure, supported by a conservative dividend policy that prioritizes capital retention and long-term stability over high current income distributions.